# A Trial Assessing Changes in Blood Sugar and the Number of Periods Where Supplementation of Carbohydrate is Needed to Treat Low Blood Sugar, During Two Different Treatment Regimens of NN1250 in Type 1 Diabetics

> **NCT00964964** · PHASE1 · COMPLETED · sponsor: **Novo Nordisk A/S** · enrollment: 18 (actual)

## Conditions studied

- Diabetes
- Diabetes Mellitus, Type 1

## Interventions

- **DRUG:** insulin degludec
- **DRUG:** insulin degludec
- **DRUG:** placebo

## Key facts

- **NCT ID:** NCT00964964
- **Lead sponsor:** Novo Nordisk A/S
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-08
- **Primary completion:** 2009-09
- **Final completion:** 2009-09
- **Target enrollment:** 18 (ACTUAL)
- **Last updated:** 2013-11-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00964964

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00964964, "A Trial Assessing Changes in Blood Sugar and the Number of Periods Where Supplementation of Carbohydrate is Needed to Treat Low Blood Sugar, During Two Different Treatment Regimens of NN1250 in Type 1 Diabetics". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT00964964. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*